Skip to contentShabet Rose Sharon — RayzeBio, Inc. insider: 21 transactions · InsiderLensShabet Rose Sharon
- 10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
- 10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
- 10% owner at APi Group Corp · on record since Mar 7, 2024
- 10% owner at Glori Energy Inc. · on record since Jun 7, 2024
- 10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
- 10% owner at FIGS, Inc. · on record since Jun 7, 2021
- 10% owner at GENENTECH INC · on record since Sep 23, 2021
- 10% owner at Myovant Sciences Ltd. · on record since Jul 10, 2017
- 10% owner at TASER INTERNATIONAL INC · on record since Jul 10, 2017
- 10% owner at Arbutus Biopharma Corp · on record since Jul 10, 2017
- 10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
- 10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
- 10% owner at ADAPTEC INC · on record since Jun 26, 2019
- Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
- Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
- Former 10% Owner at TASER INTERNATIONAL INC · on record since Jul 12, 2019
- Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
- 10% owner at ADVANCED PHOTONIX INC · on record since Apr 28, 2020
- 10% owner at Zentalis Pharmaceuticals, Inc. · on record since Apr 8, 2020
- 10% owner at Inhibrx Biosciences, Inc. · on record since Aug 28, 2020
- 10% owner at 4D Molecular Therapeutics, Inc. · on record since Dec 17, 2020
- 10% owner at PROCEPT BioRobotics Corp · on record since Sep 21, 2021
- 10% owner at Rallybio Corp · on record since Aug 2, 2021
- 10% owner at Roivant Sciences Ltd. · on record since Oct 1, 2021
- 10% owner at Amylyx Pharmaceuticals, Inc. · on record since Jan 13, 2022
- 10% owner at Frazier Lifesciences Acquisition Corp · on record since Nov 25, 2022
Insider trading activity of Shabet Rose Sharon
- Transactions on record
- 21
- since Jun 14, 2019
- Open-market buys
- 7
- $118.8M
- Open-market sells
- 2
- $9.4M
- Companies traded
- 5
- last filing Sep 21, 2023
Figures computed from official regulatory filings — methodology.
Companies where Shabet Rose Sharon has traded
Track record of Shabet Rose Sharon
Statistical track record
Free- Open-market buys
- 7
- Last buy
- Sep 19, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Shabet Rose Sharon
Co-insiders of Shabet Rose Sharon
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4D Molecular Therapeutics, Inc. +13
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Sep 21, 2023 | OtherD | -864,509 | — | — | SEC |
| Sep 21, 2023 | Other | 1,285,223 | — | — | SEC |
| Sep 21, 2023 | Other | 494,687 | — | — | SEC |
| Sep 21, 2023 | OtherD | -2,609,392 | — | — | SEC |
| Sep 21, 2023 | Other | 2,609,392 | — | — | SEC |
| Sep 21, 2023 | OtherD | -1,285,223 | — | — | SEC |
| Sep 21, 2023 | Other | 864,509 | — | — | SEC |
| Sep 21, 2023 | OtherD | -432,254 | — | — | SEC |
| Sep 21, 2023 | Buy | 458,333 | 18.00 USD | $8.2M | SEC |
| Sep 21, 2023 | Buy | 930,556 | 18.00 USD | $16.8M | SEC |
| May 11, 2023 | Buy | 850,000 | 16.00 USD | $13.6M | SEC |
| Sep 3, 2021 | Sell | -157,587 | 47.28 USD | $7.5M | SEC |
| Sep 3, 2021 | Sell | -42,413 | 44.92 USD | $1.9M | SEC |
| Jun 28, 2019 | Other | 10,178,954 | — | — | SEC |
| Jun 28, 2019 | Buy | 4,705,900 | 17.00 USD | $80M | SEC |
| Jun 28, 2019 | OtherD | -51,781,276 | — | — | SEC |
| Jun 28, 2019 | Other | 11,736,137 | — | — | SEC |
| Jun 28, 2019 | OtherD | -50,446,451 | — | — | SEC |
| Jun 14, 2019 | Buy | 7,144 | 7.91 USD | $56.5K | SEC |
| Jun 14, 2019 | Buy | 7,367 | 7.95 USD | $58.6K | SEC |
| Jun 14, 2019 | Buy | 7,500 | 8.30 USD | $62.3K | SEC |